全文获取类型
收费全文 | 15144篇 |
免费 | 1505篇 |
国内免费 | 710篇 |
专业分类
耳鼻咽喉 | 164篇 |
儿科学 | 693篇 |
妇产科学 | 190篇 |
基础医学 | 4340篇 |
口腔科学 | 167篇 |
临床医学 | 1196篇 |
内科学 | 2817篇 |
皮肤病学 | 474篇 |
神经病学 | 975篇 |
特种医学 | 198篇 |
外国民族医学 | 6篇 |
外科学 | 591篇 |
综合类 | 1731篇 |
现状与发展 | 6篇 |
预防医学 | 448篇 |
眼科学 | 397篇 |
药学 | 602篇 |
1篇 | |
中国医学 | 60篇 |
肿瘤学 | 2303篇 |
出版年
2024年 | 45篇 |
2023年 | 233篇 |
2022年 | 536篇 |
2021年 | 664篇 |
2020年 | 608篇 |
2019年 | 606篇 |
2018年 | 503篇 |
2017年 | 567篇 |
2016年 | 610篇 |
2015年 | 668篇 |
2014年 | 880篇 |
2013年 | 1022篇 |
2012年 | 789篇 |
2011年 | 816篇 |
2010年 | 682篇 |
2009年 | 712篇 |
2008年 | 770篇 |
2007年 | 724篇 |
2006年 | 735篇 |
2005年 | 669篇 |
2004年 | 621篇 |
2003年 | 566篇 |
2002年 | 491篇 |
2001年 | 474篇 |
2000年 | 338篇 |
1999年 | 381篇 |
1998年 | 367篇 |
1997年 | 293篇 |
1996年 | 220篇 |
1995年 | 193篇 |
1994年 | 137篇 |
1993年 | 96篇 |
1992年 | 61篇 |
1991年 | 68篇 |
1990年 | 38篇 |
1989年 | 29篇 |
1988年 | 24篇 |
1987年 | 15篇 |
1986年 | 10篇 |
1985年 | 19篇 |
1984年 | 12篇 |
1983年 | 8篇 |
1982年 | 14篇 |
1981年 | 12篇 |
1980年 | 11篇 |
1979年 | 6篇 |
1978年 | 3篇 |
1977年 | 5篇 |
1976年 | 3篇 |
1970年 | 5篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
31.
石棉相关肿瘤p53基因突变的免疫组化及PCR—SSCP研究 总被引:3,自引:0,他引:3
为了分析石棉相关肿瘤p53基因的突变特点,对石蜡包埋的石棉相关肿瘤p53基因突变体蛋白的表达进行了免疫组化观察,提取染色体DNA,对p53基因的第5、7、8外显子进行PCR-SSCP及测序分析。免疫组化观察发现:在分析的10例病例中有5例阳性。PCR-SSCP分析发现7例(8处)发生突变,其中4处集中在第8外显子上。5例腺癌中有4例发生p53基因突变。测序发现热点区突变。提示:石棉相关肿瘤p53基因突变率高。 相似文献
32.
Yoshito Matsui Tomoatsu Kimura Noriyuki Tsumaki Haruhiko Nakahara Nobuhito Araki Natsuo Yasui Takahiro Ochi 《Journal of orthopaedic science》1996,1(2):130-135
Recent DNA studies performed by several groups have detected mutations of the gene encoding fibroblast growth factor receptor
3 (FGFR3) in patients with achondroplasia-group disorders, including achondroplasia (ACH), hypochondroplasia (HCH), and thanatophoric
dysplasia (TD). For this study, we analyzed theFGFR3 gene in 31 Japanese patients with typical ACH, four with HCH, three with a condition intermediate between ACH and HCH (ACH/HCH-intermediate),
and one with TD. Of the 31 typical ACH patients, 29 showed a G1138 to A transition and the other two a G1138 to C transversion,
both resulting in a common Gly380Arg substitution in the transmembrane domain of FGFR3. The one TD and the four HCH patients
did not display any mutations in the transmembrane domain of FGFR3. Of the three ACH/HCH-intermediate cases, one patient showed
the Gly380Arg substitution and one did not, and further analysis of the second patient revealed the presence of Asn540Lys
substitution. The first patient was, therefore, genotypically diagnosed as ACH and the second as HCH. Peripheral blood leukocyte
DNA analysis in the remaining ACH/HCH-intermediate patient indicated an unequal ratio of mutant to normal PCR products, possibly
representing a somatic mosaic for the Gly380Arg mutation. Analysis of the common FGFR3 mutation thus appears to help in the
molecular diagnosis of patients with achondroplasia-group disorders. 相似文献
33.
34.
Stefan Somlo 《Clinical and experimental nephrology》1998,2(3):211-217
Conclusion The past decade has seen extraordinary progress in the study of autosomal-dominant polycystic kidney disease. The 2 major
genes for this disorder have been identified. Animal models of ADPKD have been produced. The molecular basis of the disease
has been characterized. ADPKD is a “second-hit” disease, much like many cancer predisposition syndromes. This has profound
implications for our understanding. The progression of ADPKD in individual patients is likely related more to their individual
rate of acquisition of second hits at thePKD1 orPKD2 locus than to the inherited germ line mutation itself. Therapeutic approaches will perhaps now be considered, which will
include interventions that may limit the rate at which somatic mutations occur in the kidney. The major focus of research
at present is to elucidate the normal functions ofPKD1 andPKD2. Protein binding partners are being sought for both proteins. The possible calcium channel function ofPKD2 is being investigated. The downstream effects of cellular deficiency of either protein are likely to yield many clues. Modifying
genetic factors that may independently affect disease progression are likely to be identified using the several mouse models.
Perhaps the next decade will bring great strides in understanding and in potential therapy for this common disease.
This paper was presented at the 2nd International Forum “The Frontiers of Nephrology,” Tokyo, May 10, 1998. 相似文献
35.
Loeys B De Backer J Van Acker P Wettinck K Pals G Nuytinck L Coucke P De Paepe A 《Human mutation》2004,24(2):140-146
In order to estimate the contribution of mutations at the fibrillin-1 locus (FBN1) to classical Marfan syndrome (MFS) and to study possible phenotypic differences between patients with an FBN1 mutation vs. without, a comprehensive molecular study of the FBN1 gene in a cohort of 93 MFS patients fulfilling the clinical diagnosis of MFS according to the Ghent nosology was performed. The initial mutation screening by CSGE/SSCP allowed identification of an FBN1-mutation in 73 patients. Next, sequencing of all FBN1-exons was performed in 11 mutation-negative patients, while in nine others, DHPLC was used. This allowed identification of seven and five additional mutations, respectively. Southern blot analysis revealed an abnormal hybridization pattern in one more patient. A total of 23 out of the 85 mutations identified here are reported for the first time. Phenotypic comparison of MFS patients with cysteine-involving mutations vs. premature termination mutations revealed significant differences in ocular and skeletal involvement. The phenotype of the eight patients without proven FBN1 mutation did not differ from the others with respect to the presence of major cardiac, ocular, and skeletal manifestations or positive familial history. Most likely, a portion of FBN1-mutations remains undetected because of technical limitations. In conclusion, the involvement of the FBN1-gene could be demonstrated in at least 91% of all MFS patients (85/93), which strongly suggests that this gene is the predominant, if not the sole, locus for MFS. 相似文献
36.
Single nucleotide polymorphisms in the protamine-1 and -2 genes of fertile and infertile human male populations 总被引:6,自引:0,他引:6
Tanaka H Miyagawa Y Tsujimura A Matsumiya K Okuyama A Nishimune Y 《Molecular human reproduction》2003,9(2):69-73
Although various genetic factors have been implicated in human male infertility, the causative genes for the different types of idiopathic male infertility have not been elucidated. Protamines, which are the major DNA-binding proteins in the sperm nucleus, package the DNA into the sperm head. Analysis of the human protamine-1 (PRM1) and -2 (PRM2) gene sequences in 226 sterile male patients and in 270 proven-fertile male volunteers revealed four single nucleotide polymorphisms (SNPs) in the PRM1 coding region, which did not cause any amino acid substitutions, and one SNP in the PRM2 gene, which produced translation termination. We also observed one SNP in the 3' non-coding region of the PRM1 gene, and two SNPs within the intron of the PRM2 gene. The prevalence of these SNPs was similar in both infertile patients and in proven-fertile volunteers, except that the c248t alteration in the PRM2 gene induced a nonsense codon under conditions of heterozygosity in one infertile patient. Although the PRM1 and PRM2 genes are highly conserved, the single SNP in the PRM2 gene that induces translation termination may result in male infertility due to haploinsufficiency of PRM2. 相似文献
37.
38.
H. R. van Doorn P. E. W. de Haas K. Kremer C. M. J. E. Vandenbroucke-Grauls M. W. Borgdorff D. van Soolingen 《Clinical microbiology and infection》2006,12(8):769-775
A previous limited study demonstrated that Mycobacterium tuberculosis isolates with a mutation at amino-acid position 315 of katG (Delta315) exhibited high-level resistance to isoniazid and were more frequently resistant to streptomycin. In the present study, isoniazid-resistant M. tuberculosis isolates from 8,332 patients in The Netherlands (1993-2002) were screened for the Delta315 mutation. Isoniazid resistance was found in 592 (7%) isolates, of which 323 (55%) carried Delta315. IS6110 restriction fragment length polymorphism analysis showed that Delta315 isolates occurred in clusters, suggesting recent transmission, at the same frequency as isoniazid-susceptible isolates. In contrast, other isoniazid-resistant isolates clustered significantly less frequently. Delta315 isolates were high-level isoniazid-resistant, streptomycin-resistant and multidrug-resistant significantly more often, and may have a greater impact on public health, than other isoniazid-resistant isolates. 相似文献
39.
Ferraris A Rappaport E Santacroce R Pollak E Krantz I Toth S Lysholm F Margaglione M Restagno G Dallapiccola B Surrey S Fortina P 《Human mutation》2002,20(4):312-320
Hereditary hearing loss (HHL) is one of the most common congenital disorders and is highly heterogeneous. Mutations in the connexin 26 (CX26) gene (GJB2) account for about 20% of all cases of childhood deafness, and approach 50% in documented recessive cases of non-syndromic hearing loss. In addition, a single mitochondrial DNA mutation, mt1555A>G, in the 12S rRNA gene (MTRNR1), is associated with familial cases of progressive deafness. Effective screening of populations for HHL necessitates rapid assessment of several of these potential mutation sites. Pyrosequencing links a DNA synthesis protocol for determining sequence to an enzyme cascade that generates light whenever pyrophosphate is released during primer strand elongation. We assessed the ability of Pyrosequencing to detect common mutations causing HHL. Detection of the most common CX26 mutations in individuals of Caucasian (35delG), Ashkenazi (167delT), and Asian (235delC, V37I) descent was confirmed by Pyrosequencing. A total of 41 different mutations in the CX26 gene and the mitochondrial mt1555A>G mutation were confirmed. Genotyping of up to six different adjacent mutations was achieved, including simultaneous detection of 35delG and 167delT. Accurate and reproducible results were achieved taking advantage of assay flexibility and experimental conditions easily optimized for a high degree of standardization and cost-effectiveness. The standardized sample preparation steps, including target amplification by PCR and preparation of single-stranded template combined with automated sequence reaction and automated genotype scoring, positions this approach as a potentially high throughput platform for SNP/mutation genotyping in a clinical laboratory setting. . 相似文献
40.